Mitigation Measures to Control the Expected Mpox Outbreak in a Developing Country—Pakistani Scenario

Abstract

Mpox (previously named Monkeypox) is one of the neglected viral infectious diseases that remained silent for a long period before finally emerging as a threat to the healthcare system in endemic regions of the world in recent years. It has been mostly centered in African countries but has now been reported in other non-endemic regions as well. While keeping a strict eye on COVID pandemic handling, there is a need to remain concerned and alert about viral threats such as Mpox infections in the future. This situation has altered the healthcare system of endemic regions, including Pakistan, to stay vigilant against the expected Mpox outbreaks in the coming months. Though no specific cases have been reported in Pakistan, the healthcare system needs to take mitigation measures to tackle an expected threat before it arrives. This is important in order to avoid another major shock to the health care system of Pakistan. Moreover, since no specific treatment is available for Mpox, we can only rely upon mitigation measures, involving preventive and treatment strategies devised around some already in-use antiviral agents against Mpox viruses. Moreover, there is an imperative need to proactively prepare the healthcare system against Mpox outbreaks, spread awareness, and involve the public in a participatory approach to stay well prepared against any such infection. Moreover, there is a need to utilize financial sources, aids, and funds wisely, to create awareness in the public about such expected healthcare outbreaks in the future.

Nanopore sequencing technology and its applications

“…16 This allows for timely identification of patients with coinfections of SARS-CoV-2 and other respiratory viruses. As the global COVID-19 pandemic continues 128 and emerging epidemics such as MPXV 129 threaten to place additional strain on medical systems in underdeveloped areas, 130 NTS offers a solution to overcome the high false negative rates of traditional RT-PCR while also monitoring for coinfections. This improves diagnostic efficiency and reduces the risk of cross-infection.…”